NCA
AGN

NCM Capital Advisers’s Allergan plc AGN Stock Holding History

NCM Capital Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,191
Closed -$685K – 94
2015
Q4 		$685K Hold
2,191
– – 1.94% 17
2015
Q3 		$596K Sell
2,191
-4,309
-66% -$1.32M 1.76% 19
2015
Q2 		$1.97M Hold
6,500
– – 2.64% 2
2015
Q1 		$1.94M Hold
6,500
– – 2.61% 2
2014
Q4 		$1.67M Buy
6,500
+550
+9% +$137K 2.35% 3
2014
Q3 		$1.44M Hold
5,950
– – 2.16% 4
2014
Q2 		$1.33M Buy
5,950
+900
+18% +$186K 1.97% 8
2014
Q1 		$1.04M Sell
5,050
-3,525
-41% -$698K 1.64% 19
2013
Q4 		$1.44M Sell
8,575
-6,350
-43% -$993K 1.48% 20
2013
Q3 		$2.15M Buy
14,925
+1,050
+8% +$140K 2.38% 4
2013
Q2 		$1.75M Buy
+13,875
New +$1.57M 1.65% 20

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

NCM Capital Advisers's AGN Position: Q1 2016 in Review

NCM Capital Advisers sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 2,191 shares — an estimated $685K sold.

NCM Capital Advisers first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $2.15M in Q3 2013. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • NCM Capital Advisers reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • NCM Capital Advisers sold 2,191 Allergan plc shares in Q1 2016, an estimated $685K.
  • NCM Capital Advisers first reported a position in Allergan plc in Q2 2013 and held it in 11 quarters.
  • NCM Capital Advisers's Allergan plc position peaked at $2.15M in Q3 2013.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on NCM Capital Advisers's 13F filing for Q1 2016, filed 6 May 2016.